Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

SeaStar Medical Holding (ICU) Shares Outstanding (Weighted Average) (2023 - 2025)

SeaStar Medical Holding (ICU) has disclosed Shares Outstanding (Weighted Average) for 3 consecutive years, with $15.5 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Shares Outstanding (Weighted Average) rose 363.26% year-over-year to $15.5 million, compared with a TTM value of $15.5 million through Sep 2025, up 363.26%, and an annual FY2024 reading of $3.7 million, up 331.88% over the prior year.
  • Shares Outstanding (Weighted Average) was $15.5 million for Q3 2025 at SeaStar Medical Holding, up from $10.0 million in the prior quarter.
  • Across five years, Shares Outstanding (Weighted Average) topped out at $15.5 million in Q3 2025 and bottomed at $559385.0 in Q2 2023.
  • Average Shares Outstanding (Weighted Average) over 3 years is $5.7 million, with a median of $3.3 million recorded in 2024.
  • Peak annual rise in Shares Outstanding (Weighted Average) hit 463.97% in 2024, while the deepest fall reached 79.39% in 2024.
  • Year by year, Shares Outstanding (Weighted Average) stood at $866813.0 in 2023, then soared by 331.88% to $3.7 million in 2024, then surged by 314.37% to $15.5 million in 2025.
  • Business Quant data shows Shares Outstanding (Weighted Average) for ICU at $15.5 million in Q3 2025, $10.0 million in Q2 2025, and $8.6 million in Q1 2025.